Haleon HLN
NYSE HLN
$9.86 -0.01 (-0.05%)
At close: Aug 20, 2026 · 11:02 AM UTC

Haleon (HLN) EBIT Margin Growth (1y) (2022 - 2023)

Haleon (HLN) EBIT Margin Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - -
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn -1,647.00
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn -368.00
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn -17.00
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn -341.00
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn -634.00
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn -538.00
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn 40.00
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Alkermes 8.19 Bn 7.53 Bn 397.90 Mn -2,010.00

Historic Data

Download Data
DateValue
Dec 31, 2023 -3,571.00
Dec 31, 2022 3,831.00